Archivio dell'Università Alfonso X El Sabio

Splicing predictions, minigene analyses, and ACMG-AMP clinical classification of 42 germline PALB2 splice-site variants

Mostra i principali dati dell'item

APA

Valenzuela Palomo, Alberto & Bueno Martínez, Elena & Sanoguera Miralles, Lara & Lorca, Víctor & Fraile Bethencourt, Eugenia & Esteban Sánchez, Ada & Gómez Barrero, Susana & Carvalho, Sara & Allen, Jamie & García Alvarez, Alicia & Pérez Segura, Pedro & Dorling, Leila & Easton, Douglas F & Devilee, Peter & Vreeswijk, Maaike PG & de la Hoya, Miguel & Velasco, Eladio A (2021-12 ) .Splicing predictions, minigene analyses, and ACMG-AMP clinical classification of 42 germline PALB2 splice-site variants.

ISO 690

Valenzuela Palomo, Alberto & Bueno Martínez, Elena & Sanoguera Miralles, Lara & Lorca, Víctor & Fraile Bethencourt, Eugenia & Esteban Sánchez, Ada & Gómez Barrero, Susana & Carvalho, Sara & Allen, Jamie & García Alvarez, Alicia & Pérez Segura, Pedro & Dorling, Leila & Easton, Douglas F & Devilee, Peter & Vreeswijk, Maaike PG & de la Hoya, Miguel & Velasco, Eladio A. 2021-12 .Splicing predictions, minigene analyses, and ACMG-AMP clinical classification of 42 germline PALB2 splice-site variants.

https://hdl.handle.net/20.500.12080/39631
dc.contributor.author Valenzuela Palomo, Alberto
dc.contributor.author Bueno Martínez, Elena
dc.contributor.author Sanoguera Miralles, Lara
dc.contributor.author Lorca, Víctor
dc.contributor.author Fraile Bethencourt, Eugenia
dc.contributor.author Esteban Sánchez, Ada
dc.contributor.author Gómez Barrero, Susana
dc.contributor.author Carvalho, Sara
dc.contributor.author Allen, Jamie
dc.contributor.author García Alvarez, Alicia
dc.contributor.author Pérez Segura, Pedro
dc.contributor.author Dorling, Leila
dc.contributor.author Easton, Douglas F
dc.contributor.author Devilee, Peter
dc.contributor.author Vreeswijk, Maaike PG
dc.contributor.author de la Hoya, Miguel
dc.contributor.author Velasco, Eladio A
dc.date.accessioned 2024-02-09T09:26:30Z
dc.date.available 2024-02-09T09:26:30Z
dc.date.created 2021-12
dc.date.issued 2021-12
dc.identifier.uri https://hdl.handle.net/20.500.12080/39631
dc.description.abstract PALB2 loss-of-function variants confer high risk of developing breast cancer. Here we present a systematic functional analysis of PALB2 splice-site variants detected in approximately 113,000 women in the large-scale sequencing project Breast Cancer After Diagnostic Gene Sequencing (BRIDGES; https://bridges-research.eu/). Eighty-two PALB2 variants at the intron-exon boundaries were analyzed with MaxEntScan. Forty-two variants were selected for the subsequent splicing functional assays. For this purpose, three splicing reporter minigenes comprising exons 1¿12 were constructed. The 42 potential spliceogenic variants were introduced into the minigenes by site directed mutagenesis and assayed in MCF-7/MDA-MB-231 cells. Splicing anomalies were observed in 35 variants, 23 of which showed no traces or minimal amounts of the expected full-length transcripts of each minigene. More than 30 different variant-induced transcripts were characterized, 23 of which were predicted to truncate the PALB2 protein. The pathogenicity of all variants was interpreted according to an in-house adaptation of the American College of Medical Genetics and Genomics and the Association for Molecular Pathology (ACMG-AMP) variant clas sification scheme. Up to 23 variants were classified as pathogenic/likely pathogenic. Remarkably, three 1,2 variants (c.49-2A>T, c.108+2T>C, and c.211+1G>A) were classified as variants of unknown significance, as they produced significant amounts of either in-frame transcripts of unknown impact on the PALB2 protein function or the minigene full-length transcripts. In conclusion, we have significantly contributed to the ongoing effort of identifying spliceo genic variants in the clinically relevant PALB2 cancer susceptibility gene. Moreover, we suggest some approaches to classify the findings in accordance with the ACMG-AMP rationale. © 2021 The Authors. The Journal of Pathology published by John Wiley & Sons, Ltd on behalf of The Pathological Society of Great Britain and Ireland. Keywords: breast cancer; susceptibility genes; PALB2; splicing; aberrant splicing; VUS; functional assay; minigene; clinical interpretation es_ES
dc.format application/pdf es_ES
dc.language eng es_ES
dc.rights CC-BY es_ES
dc.rights.uri http://creativecommons.org/licenses/by/4.0/deed.es es_ES
dc.title Splicing predictions, minigene analyses, and ACMG-AMP clinical classification of 42 germline PALB2 splice-site variants es_ES
dc.type info:eu-repo/semantics/article es_ES
dc.rights.accessrights info:eu-repo/semantics/openAccess es_ES
dc.identifier.location N/A es_ES


Files in questo item

Questo item appare nelle seguenti collezioni

Mostra i principali dati dell'item

CC-BY Except where otherwise noted, this item's license is described as CC-BY

Cerca in DSpace


Ricerca

My Account

Social Media